Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.08 USD | -0.28% | +6.39% | +57.27% |
05-02 | Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss | MT |
05-02 | Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.27% | 2B | |
+6.81% | 113B | |
+10.94% | 106B | |
+0.90% | 22.27B | |
-12.56% | 22.22B | |
-5.43% | 19.43B | |
-37.85% | 17.87B | |
-6.80% | 17.24B | |
+7.85% | 14.29B | |
+34.46% | 12.52B |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- SVB Leerink Adjusts Agios Pharmaceuticals' Price Target to $30 from $32, Maintains Market Perform Rating